Immunic (IMUX) Depreciation & Amortization (CF) (2013 - 2026)
Immunic (IMUX) posted Depreciation & Amortization (CF) of $33000.0 for Q1 2026, down 21.43% sequentially from $42000.0 in Q4 2025, and down 23.26% YoY from $43000.0 in Q1 2025.
Powered by 
Analysis
Immunic (IMUX) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends
Immunic has reported Depreciation & Amortization (CF) for 14 years, with the latest figure at $33000.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 23.26% year-over-year to $33000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $158000.0 (up 4.64% YoY) and the FY2025 annual result came in at $168000.0, up 25.37% from the prior year.
- Depreciation & Amortization (CF) slipped to $33000.0 in Q1 2026 per IMUX's latest filing, from $42000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $43000.0 in Q1 2025 and troughed at $17000.0 in Q3 2022.
- A 5-year average of $30764.7 and a median of $32000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) sank 52.5% in 2022, then jumped 100.0% in 2023.
- Over 5 years, Depreciation & Amortization (CF) stood at $19000.0 in 2022, then grew by 21.05% to $23000.0 in 2023, then surged by 52.17% to $35000.0 in 2024, then rose by 20.0% to $42000.0 in 2025, then slipped by 21.43% to $33000.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $33000.0, $42000.0, and $40000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 40.52 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Immunic | 546.30 Mn | 546.30 Mn | - | 34,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34,000.00 |
| Mar 31, 2026 | 33,000.00 |
| Dec 31, 2025 | 42,000.00 |
| Sep 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 43,000.00 |
| Mar 31, 2025 | 43,000.00 |
| Dec 31, 2024 | 35,000.00 |
| Sep 30, 2024 | 42,000.00 |
| Jun 30, 2024 | 31,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Dec 31, 2023 | 23,000.00 |
| Sep 30, 2023 | 34,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Mar 31, 2023 | 32,000.00 |
| Dec 31, 2022 | 19,000.00 |
| Sep 30, 2022 | 17,000.00 |
| Jun 30, 2022 | 20,000.00 |
| Mar 31, 2022 | 21,000.00 |
| Dec 31, 2021 | 40,000.00 |
| Sep 30, 2021 | 16,000.00 |